Terminated
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.
NCT05188209
- Conditions
- Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Carcinoma, Digestive System Diseases, +7 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
- Henan Tumor Hospital Zhengzhou, Henan, China
- Hubei Cancer Hospital Wuhan, Hubei, China
- Jinan Central Hospital Jinan, Shandong, China